Swipe om te navigeren naar een ander artikel
To find out which symptoms most frequently and severely affect breast cancer patients during radiotherapy and how patients manage the symptoms and unmet needs.
A cross-sectional survey was conducted with 111 patients who receive radiotherapy for breast cancer from January to April 2015 at Samsung Medical Center in Seoul, South Korea. Participants were asked about symptoms and discomfort due to radiotherapy, management methods for radiation dermatitis, unmet needs for radiation dermatitis care, and clinical and socio-demographic information.
Of total, 108 out of 111 patients (97.3%) reported symptoms related to radiation dermatitis. Hyperpigmentation was the most commonly reported uncomfortable symptom followed by erythema. On average, patients reported 8.6 radiotherapy-induced skin problems (range, 0–11). Of total, 59 (53.2%) patients stated that they wanted care for radiation dermatitis, and 80.0, 59.4, and 51% of patients searched for information, used products, and visited the hospital to manage radiotherapy-related skin problems. Patients who experienced dryness, burning feelings, irritation, roughness, and hyperpigmentation were 11.73, 7.02, 5.10, 4.27, and 2.80 times more likely to have management needs than patients without those symptoms, respectively, adjusting age, current cycle of radiation therapy, chemotherapy, and type of surgery.
Most of the breast cancer patients experience multiple symptoms associated with radiation dermatitis. Hyperpigmentation was the most common and uncomfortable symptom followed by erythema. Majority of patients wanted management for radiation dermatitis and patients who experienced dryness, burning feelings, irritation, roughness, and hyperpigmentation had higher needs for radiation dermatitis management.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Neben-Wittich, M. A., Atherton, P. J., Schwartz, D. J., Sloan, J. A., Griffin, P. C., Deming, R. L., Anders, J. C., Loprinzi, C. L., Burger, K. N., Martenson, J. A., & Miller, R. C. (2011). Comparison of provider-assessed and patient-reported outcome measures of acute skin toxicity during a Phase III trial of mometasone cream versus placebo during breast radiotherapy: The North Central Cancer Treatment Group (N06C4). International Journal of Radiation Oncology, Biology, Physics, 81(2), 397–402. CrossRefPubMed
Basch, E., Iasonos, A., McDonough, T., Barz, A., Culkin, A., Kris, M. G., Scher, H. I., & Schrag, D. (2006). Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study. The Lancet Oncology, 7(11), 903–909. CrossRefPubMed
Chen, A. P., Setser, A., Anadkat, M. J., Cotliar, J., Olsen, E. A., Garden, B. C., & Lacouture, M. E. (2012). Grading dermatologic adverse events of cancer treatments: the Common Terminology Criteria for Adverse Events Version 4.0. Journal of the American Academy of Dermatology, 67(5), 1025–1039. CrossRefPubMed
Harsolia, A., Kestin, L., Grills, I., Wallace, M., Jolly, S., Jones, C., Lala, M., Martinez, A., Schell, S., & Vicini, F. A. (2007). Intensity-modulated radiotherapy results in significant decrease in clinical toxicities compared with conventional wedge-based breast radiotherapy. International Journal of Radiation Oncology, Biology, Physics, 68(5), 1375–1380. CrossRefPubMed
Kang, H. C., Ahn, S. D., Choi, D. H., Kang, M. K., Chung, W. K., & Wu, H. G. (2014). The safety and efficacy of EGF-based cream for the prevention of radiotherapy-induced skin injury: results from a multicenter observational study. Radiation Oncology Journal, 32(3), 156–162. CrossRefPubMedPubMedCentral
FDA. (2006). Draft guidance for industry on patient-reported outcome measures: Use in medicinal product development to support labeling claims. Fed Register, 71, 5862–5863.
Kluetz, P. G., Chingos, D. T., Basch, E. M., & Mitchell, S. A. (2016). Patient-reported outcomes in cancer clinical trials: Measuring symptomatic adverse events with the national cancer institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). American Society of Clinical Oncology Educational Book, 35, 67–73. CrossRefPubMed
Harris, R., Probst, H., Beardmore, C., James, S., Dumbleton, C., Bolderston, A., Faithfull, S., Wells, M., & Southgate, E. (2012). Radiotherapy skin care: A survey of practice in the UK. Radiography, 18(1), 21–27. CrossRef
Bolderston, A., Lloyd, N. S., Wong, R. K., Holden, L., Robb-Blenderman, L., & Supportive Care Guidelines Group of Cancer Care Ontario Program in Evidence-Based, C. (2006). The prevention and management of acute skin reactions related to radiation therapy: a systematic review and practice guideline. Support Care Cancer, 14(8), 802–817. CrossRefPubMed
Atherton, P. J., Burger, K. N., Loprinzi, C. L., Neben Wittich, M. A., Miller, R. C., Jatoi, A., & Sloan, J. A. (2012). Using the Skindex-16 and common terminology criteria for adverse events to assess rash symptoms: Results of a pooled-analysis (N0993). Supportive Care in Cancer, 20(8), 1729–1735. CrossRefPubMed
Huang, C. J., Hou, M. F., Luo, K. H., Wei, S. Y., Huang, M. Y., Su, S. J., Kuo, H. Y., Yuan, S. S., Chen, G. S., Chu-Sung Hu, S., & Chuang, H. Y. (2015). RTOG, CTCAE and WHO criteria for acute radiation dermatitis correlate with cutaneous blood flow measurements. Breast, 24(3), 230–236. CrossRefPubMed
Szumacher, E., Wighton, A., Franssen, E., Chow, E., Tsao, M., Ackerman, I., Andersson, L., Kim, J., Wojcicka, A., Ung, Y., Sixel, K., & Hayter, C. (2001). Phase II study assessing the effectiveness of Biafine cream as a prophylactic agent for radiation-induced acute skin toxicity to the breast in women undergoing radiotherapy with concomitant CMF chemotherapy. International Journal of Radiation Oncology, Biology, Physics, 51(1), 81–86. CrossRefPubMed
McGale, P., Taylor, C., Correa, C., Cutter, D., Duane, F., Ewertz, M., Gray, R., Mannu, G., Peto, R., Whelan, T., Wang, Y., Wang, Z., & Darby, S. (2014). Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet, 383(9935), 2127–2135. CrossRefPubMed
Darby, S., McGale, P., Correa, C., Taylor, C., Arriagada, R., Clarke, M., Cutter, D., Davies, C., Ewertz, M., Godwin, J., Gray, R., Pierce, L., Whelan, T., Wang, Y., & Peto, R. (2011). Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet, 378(9804), 1707–1716. CrossRefPubMed
Lee, S. Y., Kwon, H. C., Kim, J. S., & Lee, H.-K. (2010). An analysis of the incidence and related factors for radiation dermatitis in breast cancer patients who received radiation therapy. The Journal of the Korean Society for Therapeutic Radiology and Oncology, 28(1), 16. CrossRef
Vogelzang, N. J., Breitbart, W., Cella, D., Curt, G. A., Groopman, J. E., Horning, S. J., Itri, L. M., Johnson, D. H., Scherr, S. L., & Portenoy, R. K. (1997). Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Seminars in Hematology, 34(3 Suppl 2), 4–12. PubMed
Patrick, D. L., Ferketich, S. L., Frame, P. S., Harris, J. J., Hendricks, C. B., Levin, B., Link, M. P., Lustig, C., McLaughlin, J., Ried, L. D., Turrisi, A. T. 3rd, Unutzer, J., & Vernon, S. W. (2003). National institutes of health state-of-the-science conference statement: Symptom management in cancer: Pain, depression, and fatigue, July 15–17, 2002. Journal of the National Cancer Institute, 95(15), 1110–1117. CrossRefPubMed
Noh, J. M., Choi, D. H., Park, H., Huh, S. J., Park, W., Seol, S. W., Jeong, B. K., Nam, S. J., Lee, J. E., & Kil, W. H. (2014). Comparison of acute skin reaction following morning versus late afternoon radiotherapy in patients with breast cancer who have undergone curative surgical resection. Journal of Radiation Research, 55(3), 553–558. CrossRefPubMedPubMedCentral
- Patient-reported symptoms of radiation dermatitis during breast cancer radiotherapy: a pilot study
Doo Ho Choi
Seung Jae Huh
- Springer International Publishing